Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist-Reference-Cited by-同舟云学术

Cebranopadol: A Novel Potent Analgesic Nociceptin/Orphanin FQ Peptide and Opioid Receptor Agonist

Published:2014-04-08 Issue:3 Volume:349 Page:535-548
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Linz Klaus,Christoph Thomas,Tzschentke Thomas M.,Koch Thomas,Schiene Klaus,Gautrois Michael,Schröder Wolfgang,Kögel Babette Y.,Beier Horst,Englberger Werner,Schunk Stefan,De Vry Jean,Jahnel Ulrich,Frosch Stefanie

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference57 articles.

1. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

2. Loss of antiallodynic and antinociceptive spinal/supraspinal morphine synergy in nerve-injured rats: restoration by MK-801 or dynorphin antiserum

3. Up-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injury

4. A limited arthritic model for chronic pain studies in the rat

5. Calo G Guerrini R (2013) Medicinal chemistry, pharmacology, and biological actions of peptide ligands selective for the nociceptin/orphanin FQ receptor, in Research and Development of Opioid-Related Ligands ( Ko MC Husbands SM , eds) pp 275–325, American Chemical Society, Washington, DC.

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy;Neuropharmacology;2024-10

2. Novel chimeric peptides based on endomorphins and ghrelin receptor antagonist produced supraspinal antinociceptive effects with reduced acute tolerance in mice;Biochimie;2024-08

3. Advances in attenuating opioid-induced respiratory depression: A narrative review;Medicine;2024-07-19

4. Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach;Medicinal Research Reviews;2024-05-15

5. NCP, a Dual Kappa and Mu Opioid Receptor Agonist, Is a Potent Analgesic Against Inflammatory Pain without Reinforcing or Aversive Properties;Journal of Pharmacology and Experimental Therapeutics;2024-02-26